7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 
      
    		                                                                   
      assets
    		                                                                   
      current assets:
    		                                                                   
      cash and cash equivalents
    		997,000,000 939,000,000 1,060,000,000 1,933,000,000 2,888,000,000 831,000,000 1,284,000,000 935,000,000 891,000,000 862,000,000 842,000,000 908,000,000 999,000,000 858,000,000 2,371,000,000 1,451,000,000 1,027,000,000 1,120,000,000 1,030,000,000 1,793,000,000 6,588,000,000 4,638,000,000 731,000,000 621,000,000 559,000,000 2,430,000,000 531,000,000 502,000,000 578,000,000 868,000,000 1,086,000,000 732,000,000 718,000,000 705,000,000 753,000,000 646,000,000 677,000,000 691,000,000 852,000,000 741,000,000 588,000,000 673,000,000 586,000,000 566,000,000 515,000,000 658,000,000 850,000,000 414,000,000 484,000,000 462,000,000 594,000,000 705,000,000 472,000,000 518,000,000 471,000,000 373,000,000 359,000,000 539,000,000 553,000,000 411,000,000 377,000,000 350,000,000 388,000,000 312,000,000 443,000,000 450,000,000 356,000,000 
      accounts receivable
    		10,428,000,000 10,459,000,000 11,088,000,000 10,751,000,000 9,915,000,000 10,239,000,000 10,044,000,000 9,958,000,000 9,182,000,000 8,713,000,000 8,657,000,000 8,891,000,000 8,552,000,000 8,628,000,000 8,520,000,000 8,095,000,000 8,433,000,000 7,636,000,000 7,424,000,000 7,051,000,000 6,433,000,000 6,139,000,000 6,890,000,000 7,380,000,000 7,131,000,000 7,219,000,000 7,420,000,000 6,789,000,000 6,532,000,000 6,592,000,000 6,332,000,000  -3,174,000,000 -1,752,000,000 -592,000,000  -2,044,000,000 -1,364,000,000 -789,000,000  -2,976,000,000 -1,784,000,000 -895,000,000                         
      inventories
    		1,734,000,000 1,792,000,000 1,794,000,000 1,738,000,000 1,776,000,000 1,800,000,000 1,903,000,000 2,021,000,000 2,030,000,000 2,050,000,000 2,085,000,000 2,068,000,000 2,009,000,000 2,043,000,000 2,003,000,000 1,986,000,000 2,019,000,000 2,027,000,000 2,068,000,000 2,025,000,000 1,950,000,000 1,834,000,000 1,953,000,000 1,849,000,000 1,769,000,000 1,826,000,000 1,778,000,000 1,732,000,000 1,634,000,000 1,636,000,000 1,677,000,000 1,573,000,000 1,546,000,000 1,544,000,000 1,501,000,000 1,503,000,000 1,503,000,000 1,481,000,000 1,415,000,000 1,439,000,000 1,379,000,000 1,348,000,000 1,287,000,000 1,279,000,000 1,258,000,000 1,211,000,000 1,187,000,000 1,179,000,000 1,135,000,000 1,152,000,000 1,104,000,000 1,086,000,000 1,052,000,000 1,055,000,000 1,046,000,000 1,054,000,000 891,000,000 887,000,000 881,000,000 897,000,000 815,000,000 805,000,000 794,000,000 802,000,000 745,000,000 730,000,000 717,000,000 
      other
    		2,126,000,000 2,373,000,000 2,316,000,000 1,992,000,000 2,083,000,000 2,303,000,000 2,051,000,000 2,013,000,000 2,191,000,000 2,263,000,000 1,957,000,000 1,776,000,000 1,921,000,000 2,408,000,000 2,112,000,000 2,010,000,000 1,769,000,000 1,692,000,000 1,514,000,000 1,464,000,000 1,295,000,000 1,420,000,000 1,442,000,000 1,346,000,000 1,310,000,000 1,394,000,000 1,379,000,000 1,190,000,000 1,266,000,000 1,298,000,000 1,296,000,000 1,171,000,000 1,204,000,000 1,306,000,000 1,119,000,000 1,111,000,000 1,160,000,000 1,254,000,000 1,054,000,000 1,163,000,000 1,015,000,000 1,092,000,000 1,025,000,000 1,025,000,000 910,000,000 931,000,000 859,000,000 747,000,000 828,000,000 861,000,000 827,000,000 915,000,000 828,000,000 756,000,000 661,000,000 679,000,000 875,000,000 625,000,000 576,000,000 848,000,000 678,000,000 742,000,000 497,000,000 579,000,000 515,000,000 556,000,000 558,000,000 
      property and equipment, at cost
    		65,489,000,000 64,388,000,000 63,680,000,000  61,750,000,000 60,625,000,000 59,440,000,000  57,772,000,000 56,667,000,000 55,463,000,000  53,730,000,000 52,816,000,000 52,042,000,000  50,695,000,000 50,698,000,000 49,877,000,000  48,775,000,000 48,484,000,000 47,861,000,000  46,295,000,000 45,369,000,000 44,583,000,000  41,978,000,000 41,142,000,000 40,308,000,000  39,262,000,000 38,306,000,000 37,588,000,000  36,449,000,000 35,873,000,000 34,978,000,000  34,207,000,000 33,803,000,000 33,293,000,000  32,301,000,000 31,841,000,000 31,369,000,000  30,472,000,000 30,077,000,000 29,764,000,000  29,145,000,000 28,742,000,000 28,354,000,000  26,647,000,000 26,338,000,000 25,855,000,000  25,226,000,000 24,950,000,000 24,766,000,000  24,389,000,000 24,185,000,000 23,913,000,000 
      accumulated depreciation
    		-34,921,000,000 -34,265,000,000 -33,942,000,000 -33,100,000,000 -32,703,000,000 -31,986,000,000 -31,344,000,000 -30,833,000,000 -30,655,000,000 -30,023,000,000 -29,410,000,000 -29,182,000,000 -28,752,000,000 -28,229,000,000 -27,814,000,000 -27,287,000,000 -27,148,000,000 -27,227,000,000 -26,689,000,000 -26,118,000,000 -25,834,000,000 -25,413,000,000 -24,876,000,000 -24,520,000,000 -24,293,000,000 -23,902,000,000 -23,455,000,000 -23,208,000,000 -22,937,000,000 -22,598,000,000 -22,184,000,000 -22,189,000,000 -21,933,000,000 -21,538,000,000 -21,126,000,000 -20,703,000,000 -20,574,000,000 -20,249,000,000 -19,921,000,000 -19,600,000,000 -19,503,000,000 -19,243,000,000 -18,901,000,000 -18,625,000,000 -18,423,000,000 -18,120,000,000 -17,757,000,000 -17,454,000,000 -17,150,000,000 -16,848,000,000 -16,620,000,000 -16,342,000,000 -16,185,000,000 -15,896,000,000 -15,567,000,000 -15,241,000,000 -15,002,000,000 -14,754,000,000 -14,508,000,000 -14,289,000,000 -14,090,000,000 -13,798,000,000 -13,514,000,000 -13,242,000,000 -13,038,000,000 -12,752,000,000 -12,458,000,000 
      investments of insurance subsidiaries
    		573,000,000 531,000,000 550,000,000 569,000,000 553,000,000 483,000,000 471,000,000 477,000,000 382,000,000 384,000,000 390,000,000 381,000,000 372,000,000 379,000,000 408,000,000 438,000,000 418,000,000 410,000,000 393,000,000 388,000,000 390,000,000 364,000,000 325,000,000 315,000,000 357,000,000 342,000,000 338,000,000 362,000,000 367,000,000 414,000,000 417,000,000 418,000,000 368,000,000 352,000,000 349,000,000 336,000,000 354,000,000 341,000,000 425,000,000 432,000,000 409,000,000 404,000,000 435,000,000 494,000,000 441,000,000 426,000,000 453,000,000 448,000,000 402,000,000 405,000,000 423,000,000 515,000,000 473,000,000 495,000,000 536,000,000 548,000,000            
      investments in and advances to affiliates
    		654,000,000 654,000,000 657,000,000 662,000,000 705,000,000 702,000,000 736,000,000 756,000,000 739,000,000 731,000,000 786,000,000 823,000,000 444,000,000 435,000,000 441,000,000 448,000,000 412,000,000 382,000,000 427,000,000 422,000,000 335,000,000 275,000,000 238,000,000 249,000,000 243,000,000 247,000,000 246,000,000 232,000,000 238,000,000 234,000,000 231,000,000 199,000,000 201,000,000 197,000,000 194,000,000 206,000,000 216,000,000 201,000,000 174,000,000 178,000,000 186,000,000 182,000,000 181,000,000 165,000,000 167,000,000 150,000,000 142,000,000 121,000,000 125,000,000 120,000,000 107,000,000 104,000,000 103,000,000 102,000,000 108,000,000 101,000,000 837,000,000 843,000,000 852,000,000 869,000,000 857,000,000 870,000,000 851,000,000 853,000,000 855,000,000 854,000,000 860,000,000 
      goodwill and other intangible assets
    		10,275,000,000 10,273,000,000 10,237,000,000 10,093,000,000 9,982,000,000 9,963,000,000 9,967,000,000 9,945,000,000 9,778,000,000 9,641,000,000 9,590,000,000 9,653,000,000 9,651,000,000 9,593,000,000 9,525,000,000 9,540,000,000 9,153,000,000 8,680,000,000 8,575,000,000 8,578,000,000 8,570,000,000 8,578,000,000 8,587,000,000 8,269,000,000 8,160,000,000 8,140,000,000 8,159,000,000 7,953,000,000 7,759,000,000 7,459,000,000 7,471,000,000 7,394,000,000 7,357,000,000 6,771,000,000 6,754,000,000 6,704,000,000 6,691,000,000 6,694,000,000 6,713,000,000 6,731,000,000 6,540,000,000 6,484,000,000 6,415,000,000 6,416,000,000 5,899,000,000 5,909,000,000 5,910,000,000 5,903,000,000 5,832,000,000 5,534,000,000 5,541,000,000 5,539,000,000 5,460,000,000 5,431,000,000 5,398,000,000 5,251,000,000            
      right-of-use operating lease assets
    		2,115,000,000 2,156,000,000 2,132,000,000 2,131,000,000 2,201,000,000 2,179,000,000 2,211,000,000 2,207,000,000 2,079,000,000 2,110,000,000 2,032,000,000 2,065,000,000 2,097,000,000 2,139,000,000 2,138,000,000 2,113,000,000 2,099,000,000 2,118,000,000 2,083,000,000 2,024,000,000 1,972,000,000 1,863,000,000 1,828,000,000 1,834,000,000 1,770,000,000 1,787,000,000 1,812,000,000                                         
      liabilities and stockholders’ (deficit) equity
    		                                                                   
      current liabilities:
    		                                                                   
      accounts payable
    		4,552,000,000 4,250,000,000 4,488,000,000 4,276,000,000 4,235,000,000 4,029,000,000 4,735,000,000 4,233,000,000 4,139,000,000 3,823,000,000 3,769,000,000 4,239,000,000 4,161,000,000 3,742,000,000 4,010,000,000 4,111,000,000 3,759,000,000 3,531,000,000 3,524,000,000 3,535,000,000 3,270,000,000 2,882,000,000 2,750,000,000 2,905,000,000 2,610,000,000 2,609,000,000 2,693,000,000 2,577,000,000 2,414,000,000 2,457,000,000 2,538,000,000 2,606,000,000 2,314,000,000 2,245,000,000 2,233,000,000 2,318,000,000 1,950,000,000 1,934,000,000 1,944,000,000 2,170,000,000 1,877,000,000 1,884,000,000 1,973,000,000 2,035,000,000 1,787,000,000 1,717,000,000 1,735,000,000 1,803,000,000 1,582,000,000 1,657,000,000 1,691,000,000 1,768,000,000 1,585,000,000 1,517,000,000 1,412,000,000 1,597,000,000 1,334,000,000 1,297,000,000 1,348,000,000 1,537,000,000 1,254,000,000 1,179,000,000 1,199,000,000 1,460,000,000 1,199,000,000 1,206,000,000 1,200,000,000 
      accrued salaries
    		2,294,000,000 2,072,000,000 1,857,000,000 2,304,000,000 2,164,000,000 1,993,000,000 1,759,000,000 2,127,000,000 1,912,000,000 1,776,000,000 1,565,000,000 1,712,000,000 1,625,000,000 1,895,000,000 1,865,000,000 1,912,000,000 2,134,000,000 1,896,000,000 1,767,000,000 1,720,000,000 1,971,000,000 1,631,000,000 1,560,000,000 1,775,000,000 1,669,000,000 1,497,000,000 1,424,000,000 1,580,000,000 1,456,000,000 1,315,000,000 1,238,000,000 1,369,000,000 1,312,000,000 1,209,000,000 1,150,000,000 1,265,000,000 1,241,000,000 1,405,000,000 1,309,000,000 1,233,000,000 1,358,000,000 1,282,000,000 1,180,000,000 1,370,000,000 1,238,000,000 1,140,000,000 1,052,000,000 1,193,000,000 1,085,000,000 1,036,000,000 969,000,000 1,120,000,000 1,027,000,000 970,000,000 909,000,000 965,000,000 876,000,000 1,009,000,000 975,000,000 895,000,000 1,007,000,000 927,000,000 893,000,000 849,000,000 954,000,000 876,000,000 823,000,000 
      other accrued expenses
    		4,940,000,000 4,513,000,000 3,767,000,000 3,899,000,000 3,819,000,000 3,705,000,000 3,619,000,000 3,871,000,000 3,803,000,000 3,551,000,000 3,316,000,000 3,581,000,000 3,780,000,000 3,116,000,000 3,157,000,000 3,322,000,000 3,481,000,000 2,935,000,000 3,117,000,000 3,240,000,000 2,843,000,000 3,181,000,000 2,547,000,000 2,932,000,000 2,697,000,000 2,782,000,000 2,618,000,000 2,624,000,000 2,170,000,000 2,161,000,000 2,005,000,000 1,983,000,000 1,783,000,000 2,104,000,000 1,868,000,000 2,035,000,000 1,748,000,000 1,833,000,000 1,919,000,000 1,880,000,000 1,701,000,000 1,770,000,000 1,982,000,000 1,737,000,000 1,563,000,000 1,992,000,000 2,063,000,000 1,913,000,000 1,764,000,000 1,871,000,000 1,893,000,000 1,849,000,000 1,498,000,000 1,651,000,000 1,453,000,000 1,585,000,000 1,336,000,000 1,283,000,000 1,398,000,000 1,245,000,000 1,373,000,000 1,262,000,000 1,498,000,000 1,158,000,000 1,316,000,000 1,119,000,000 1,458,000,000 
      short-term borrowings and long-term debt due within one year
    		6,110,000,000 5,104,000,000                                                                  
      long-term debt, less debt issuance costs and discounts of 416 and 369
    		38,401,000,000                                                                   
      professional liability risks
    		1,462,000,000 1,506,000,000 1,497,000,000 1,544,000,000 1,584,000,000 1,573,000,000 1,571,000,000 1,557,000,000 1,590,000,000 1,554,000,000 1,565,000,000 1,528,000,000 1,510,000,000 1,533,000,000 1,508,000,000 1,514,000,000 1,522,000,000 1,585,000,000 1,553,000,000 1,486,000,000 1,434,000,000 1,485,000,000 1,432,000,000 1,370,000,000 1,349,000,000 1,354,000,000 1,313,000,000 1,275,000,000 1,239,000,000 1,283,000,000 1,244,000,000 1,198,000,000 1,179,000,000 1,144,000,000 1,134,000,000 1,148,000,000 1,164,000,000 1,126,000,000 1,116,000,000 1,115,000,000 1,117,000,000 1,132,000,000 1,095,000,000 1,078,000,000 1,045,000,000 1,019,000,000 978,000,000 949,000,000 959,000,000 960,000,000 970,000,000 973,000,000 962,000,000 1,039,000,000 1,030,000,000 993,000,000 993,000,000 987,000,000 1,003,000,000 995,000,000 1,027,000,000 1,029,000,000 1,058,000,000 1,057,000,000 1,097,000,000 1,108,000,000 1,098,000,000 
      right-of-use operating lease obligations
    		1,838,000,000 1,881,000,000 1,860,000,000 1,863,000,000 1,924,000,000 1,894,000,000 1,912,000,000 1,903,000,000 1,776,000,000 1,806,000,000 1,716,000,000 1,752,000,000 1,762,000,000 1,796,000,000 1,790,000,000 1,755,000,000 1,742,000,000 1,767,000,000 1,730,000,000 1,673,000,000 1,635,000,000 1,531,000,000 1,497,000,000 1,499,000,000 1,440,000,000 1,460,000,000 1,494,000,000                                         
      income taxes and other liabilities
    		2,309,000,000 2,069,000,000 2,191,000,000 2,041,000,000 1,982,000,000 1,966,000,000 1,905,000,000 1,867,000,000 1,666,000,000 1,691,000,000 1,692,000,000 1,615,000,000 1,714,000,000 1,741,000,000 1,768,000,000 2,060,000,000 2,800,000,000 2,088,000,000 2,032,000,000 1,940,000,000 1,477,000,000 1,490,000,000 1,477,000,000 1,420,000,000 1,349,000,000 1,324,000,000 1,277,000,000 1,248,000,000 1,388,000,000 1,459,000,000 1,417,000,000 1,374,000,000 1,256,000,000 1,282,000,000 1,253,000,000 1,249,000,000 1,746,000,000 1,953,000,000 1,933,000,000 1,904,000,000 1,903,000,000 1,860,000,000 1,837,000,000 1,832,000,000 1,740,000,000 1,554,000,000 1,524,000,000 1,525,000,000 1,670,000,000 1,695,000,000 1,763,000,000 1,776,000,000 1,860,000,000 1,857,000,000 1,757,000,000 1,720,000,000 1,683,000,000 1,515,000,000 1,507,000,000 1,608,000,000 1,611,000,000 1,589,000,000 1,742,000,000 1,768,000,000 1,782,000,000 1,713,000,000 1,853,000,000 
      stockholders’ (deficit) equity:
    		                                                                   
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 229,845,100 shares — 2025 and 249,981,400 shares — 2024
    		2,000,000                                                                   
      accumulated other comprehensive loss
    		-317,000,000 -309,000,000 -357,000,000 -387,000,000 -378,000,000 -433,000,000 -433,000,000 -425,000,000 -491,000,000 -456,000,000 -470,000,000 -490,000,000 -592,000,000 -515,000,000 -447,000,000 -404,000,000 -492,000,000 -475,000,000 -491,000,000 -502,000,000 -515,000,000 -562,000,000 -571,000,000 -460,000,000 -461,000,000 -431,000,000 -374,000,000 -381,000,000 -266,000,000 -261,000,000 -197,000,000 -278,000,000 -268,000,000 -293,000,000 -320,000,000 -338,000,000 -341,000,000 -344,000,000 -294,000,000 -265,000,000 -309,000,000 -290,000,000 -344,000,000 -323,000,000 -206,000,000 -199,000,000 -232,000,000 -257,000,000 -374,000,000 -426,000,000 -475,000,000 -457,000,000 -440,000,000 -449,000,000 -411,000,000 -440,000,000 -424,000,000 -339,000,000 -344,000,000 -428,000,000 -494,000,000 -505,000,000 -479,000,000 -450,000,000 -505,000,000 -498,000,000 -608,000,000 
      retained deficit
    		-5,020,000,000 -4,087,000,000 -3,164,000,000 -2,115,000,000 -1,807,000,000 -1,170,000,000 -1,185,000,000 -1,352,000,000 -1,989,000,000 -1,850,000,000 -2,028,000,000 -2,280,000,000 -2,781,000,000 -3,168,000,000 -1,589,000,000      -647,000,000 -1,315,000,000 -2,394,000,000 -2,351,000,000 -3,107,000,000 -3,474,000,000 -3,983,000,000 -4,572,000,000 -5,342,000,000 -5,731,000,000 -6,051,000,000 -6,532,000,000 -6,516,000,000 -6,503,000,000 -6,701,000,000 -6,968,000,000 -7,426,000,000 -7,767,000,000 -7,266,000,000 -7,338,000,000 -6,989,000,000 -7,120,000,000 -7,280,000,000 -7,575,000,000 -8,054,000,000 -8,572,000,000 -9,055,000,000 -9,403,000,000 -9,827,000,000 -10,193,000,000 -10,616,000,000 -10,960,000,000 -9,103,000,000 -9,463,000,000 -9,854,000,000 -9,423,000,000 -11,358,000,000 -11,419,000,000 -11,648,000,000 -11,888,000,000 -10,090,000,000 -10,333,000,000 -10,126,000,000 -8,763,000,000 -8,979,000,000 -9,175,000,000 -9,457,000,000 
      stockholders’ deficit attributable to hca healthcare, inc.
    		-5,335,000,000 -4,394,000,000 -3,519,000,000 -2,499,000,000 -2,182,000,000 -1,600,000,000 -1,615,000,000 -1,774,000,000 -2,477,000,000 -2,303,000,000 -2,495,000,000 -2,767,000,000 -3,370,000,000 -3,680,000,000 -2,033,000,000      -974,000,000 -1,786,000,000 -2,962,000,000 -2,808,000,000 -3,565,000,000 -3,902,000,000 -4,354,000,000 -4,950,000,000 -5,605,000,000 -5,989,000,000 -6,244,000,000 -6,806,000,000 -6,780,000,000 -6,792,000,000 -7,017,000,000                                 
      noncontrolling interests
    		3,176,000,000 3,156,000,000 3,081,000,000 3,054,000,000 2,968,000,000 2,939,000,000 2,885,000,000 2,834,000,000 2,834,000,000 2,764,000,000 2,727,000,000 2,694,000,000 2,592,000,000 2,538,000,000 2,447,000,000 2,422,000,000 2,520,000,000 2,383,000,000 2,235,000,000 2,320,000,000 2,273,000,000 2,354,000,000 2,259,000,000 2,243,000,000 2,118,000,000 2,132,000,000 2,099,000,000 2,032,000,000 1,875,000,000 1,864,000,000 1,810,000,000 1,811,000,000 1,714,000,000 1,713,000,000 1,660,000,000 1,669,000,000 1,600,000,000 1,609,000,000 1,557,000,000 1,553,000,000 1,482,000,000 1,451,000,000 1,398,000,000 1,396,000,000 1,366,000,000 1,402,000,000 1,361,000,000 1,342,000,000 1,332,000,000 1,338,000,000 1,311,000,000 1,319,000,000 1,296,000,000 1,300,000,000 1,289,000,000 1,244,000,000 1,132,000,000 1,147,000,000 1,142,000,000 1,132,000,000 1,017,000,000 1,017,000,000 1,015,000,000 1,008,000,000 990,000,000 1,005,000,000 1,019,000,000 
      long-term debt, less debt issuance costs and discounts of 429 and 369
    		 39,379,000,000                                                                  
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 236,143,900 shares — 2025 and 249,981,400 shares — 2024
    		 2,000,000                                                                  
      long-term debt due within one year
    		  3,519,000,000 4,698,000,000 4,682,000,000 4,574,000,000 3,028,000,000 2,424,000,000 2,553,000,000 2,395,000,000 2,378,000,000 370,000,000 218,000,000 246,000,000 1,486,000,000 237,000,000 250,000,000 253,000,000 234,000,000 209,000,000 172,000,000 163,000,000 162,000,000 145,000,000 148,000,000 2,073,000,000 3,796,000,000 788,000,000 191,000,000 1,692,000,000 1,697,000,000 200,000,000 202,000,000 213,000,000 212,000,000 216,000,000 216,000,000 224,000,000 226,000,000 233,000,000 1,377,000,000 1,374,000,000 2,037,000,000 338,000,000 1,044,000,000 1,046,000,000 1,041,000,000 786,000,000 988,000,000 1,456,000,000 1,438,000,000 1,435,000,000 1,751,000,000 1,309,000,000 1,841,000,000 1,407,000,000 725,000,000 689,000,000 546,000,000 592,000,000 696,000,000 1,029,000,000 981,000,000 846,000,000 635,000,000 194,000,000 416,000,000 
      long-term debt, less debt issuance costs and discounts of 432 and 369
    		  41,057,000,000                                                                 
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 242,955,400 shares — 2025 and 249,981,400 shares — 2024
    		  2,000,000                                                                 
      property and equipment, at cost:
    		                                                                   
      land
    		   3,295,000,000    3,120,000,000    2,799,000,000    2,496,000,000    2,269,000,000    2,178,000,000    1,944,000,000    1,746,000,000    1,611,000,000    1,524,000,000    1,524,000,000    1,487,000,000    1,429,000,000    1,416,000,000    1,215,000,000    1,202,000,000    
      buildings
    		   22,691,000,000    21,560,000,000    20,221,000,000    19,211,000,000    18,471,000,000    17,669,000,000    15,659,000,000    14,249,000,000    13,546,000,000    12,533,000,000    11,941,000,000    11,211,000,000    10,720,000,000    10,231,000,000    9,438,000,000    9,108,000,000    
      equipment
    		   34,670,000,000    31,998,000,000    29,981,000,000    28,256,000,000    27,082,000,000    25,756,000,000    23,577,000,000    22,168,000,000    20,580,000,000    19,335,000,000    18,496,000,000    17,519,000,000    16,430,000,000    15,431,000,000    14,310,000,000    13,575,000,000    
      construction in progress
    		   1,858,000,000    1,870,000,000    1,756,000,000    1,387,000,000    1,495,000,000    1,632,000,000    1,785,000,000    1,921,000,000    1,318,000,000    1,222,000,000    1,019,000,000    856,000,000    948,000,000    997,000,000    678,000,000    784,000,000    
      liabilities and stockholders’ equity
    		                                                                   
      long-term debt, less debt issuance costs and discounts of 369 and 333
    		   38,333,000,000                                                                
      stockholders’ equity
    		                                                                   
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 249,981,400 shares — 2024 and 265,537,300 shares — 2023
    		   3,000,000                                                                
      long-term debt, less debt issuance costs and discounts of 378 and 333
    		    38,283,000,000                                                               
      stockholders’ equity:
    		                                                                   
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 254,517,700 shares — 2024 and 265,537,300 shares — 2023
    		    3,000,000                                                               
      long-term debt, less debt issuance costs and discounts of 371 and 333
    		     36,306,000,000                                                              
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 259,237,600 shares — 2024 and 265,537,300 shares — 2023
    		     3,000,000                                                              
      long-term debt, less debt issuance costs and discounts of 381 and 333
    		      37,163,000,000                                                             
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 263,215,800 shares — 2024 and 265,537,300 shares — 2023
    		      3,000,000                                                             
      long-term debt, less debt issuance costs and discounts of 333 and 301
    		       37,169,000,000                                                            
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 265,537,300 shares — 2023 and 277,378,300 shares — 2022
    		       3,000,000                                                            
      long-term debt, less debt issuance costs and discounts of 341 and 301
    		        36,793,000,000                                                           
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 268,967,300 shares — 2023 and 277,378,300 shares — 2022
    		        3,000,000                                                           
      long-term debt, less debt issuance costs and discounts of 349 and 301
    		         36,537,000,000                                                          
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 272,931,700 shares — 2023 and 277,378,300 shares — 2022
    		         3,000,000                                                          
      long-term debt, less debt issuance costs and discounts of 295 and 301
    		          36,478,000,000                                                         
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 275,939,900 shares — 2023 and 277,378,300 shares — 2022
    		          3,000,000                                                         
      long-term debt, less debt issuance costs and discounts of 301 and 248
    		           37,714,000,000                                                        
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 277,378,300 shares — 2022 and 305,476,800 shares — 2021
    		           3,000,000                                                        
      long-term debt, less debt issuance costs and discounts of 309 and 248
    		            37,492,000,000                                                       
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 283,903,500 shares — 2022 and 305,476,800 shares — 2021
    		            3,000,000                                                       
      long-term debt, less debt issuance costs and discounts of 316 and 248
    		             38,657,000,000                                                      
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 287,004,400 shares — 2022 and 305,476,800 shares — 2021
    		             3,000,000                                                      
      long-term debt, less debt issuance costs and discounts of 323 and 248
    		              36,210,000,000                                                     
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021
    		              3,000,000                                                     
      long-term debt, less debt issuance costs and discounts of 248 and 236
    		               34,342,000,000                                                    
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 305,476,800 shares — 2021 and 339,425,600 shares — 2020
    		               3,000,000                                                    
      capital in excess of par value
    		                   294,000,000 185,000,000 88,000,000                       872,000,000 777,000,000 1,455,000,000 1,386,000,000 1,821,000,000 1,792,000,000 1,764,000,000 1,753,000,000 1,680,000,000 1,665,000,000 1,648,000,000 1,601,000,000 1,584,000,000 3,072,000,000 3,057,000,000 389,000,000 324,000,000 312,000,000 291,000,000 226,000,000 204,000,000 186,000,000 176,000,000 
      retained earnings
    		               -532,000,000   735,000,000 777,000,000                                                
      stockholders’ equity (deficit) attributable to hca healthcare, inc.
    		               -933,000,000    572,000,000                                                
      long-term debt, less debt issuance costs and discounts of 253 and 236
    		                32,049,000,000                                                   
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 313,502,400 shares — 2021 and 339,425,600 shares — 2020
    		                3,000,000                                                   
      retained (deficit) earnings
    		                -206,000,000 -121,000,000                                                  
      stockholders’ (deficit) equity attributable to hca healthcare, inc.
    		                -695,000,000 -593,000,000                                                  
      long-term debt, less debt issuance costs and discounts of 255 and 236
    		                 32,319,000,000                                                  
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 322,824,800 shares — 2021 and 339,425,600 shares — 2020
    		                 3,000,000                                                  
      long-term debt, less debt issuance costs and discounts of 229 and 236
    		                  30,838,000,000                                                 
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 333,714,500 shares — 2021 and 339,425,600 shares — 2020
    		                  3,000,000                                                 
      stockholders’ equity attributable to hca healthcare, inc.
    		                  247,000,000                                                 
      long-term debt, less debt issuance costs and discounts of 236 and 239
    		                   30,795,000,000                                                
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 339,425,600 shares — 2020 and 338,445,600 shares — 2019
    		                   3,000,000                                                
      government stimulus refund liability
    		                    6,123,000,000                                               
      long-term debt, less debt issuance costs and discounts of 245 and 239
    		                    30,792,000,000                                               
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 338,370,500 shares in 2020 and 338,445,600 shares in 2019
    		                    3,000,000                                               
      liabilities and stockholders’ deficit
    		                                                                   
      contract liabilities-deferred revenues
    		                     4,999,000,000                                              
      long-term debt, less debt issuance costs and discounts of 252 and 239
    		                     30,779,000,000                                              
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 337,960,400 shares in 2020 and 338,445,600 shares in 2019
    		                     3,000,000                                              
      long-term debt, less debt issuance costs and discounts of 258 and 239
    		                      34,699,000,000                                             
      stockholders’ deficit:
    		                                                                   
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 337,607,500 shares in 2020 and 338,445,600 shares in 2019
    		                      3,000,000                                             
      long-term debt, less debt issuance costs and discounts of 239 and 157
    		                       33,577,000,000                                            
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 338,445,600 shares — 2019 and 342,895,200 shares — 2018
    		                       3,000,000                                            
      long-term debt, less debt issuance costs and discounts of 244 and 157
    		                        34,097,000,000                                           
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 340,053,100 shares in 2019 and 342,895,200 shares in 2018
    		                        3,000,000                                           
      long-term debt, less debt issuance costs and discounts of 252 and 157
    		                         34,120,000,000                                          
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 341,516,800 shares in 2019 and 342,895,200 shares in 2018
    		                         3,000,000                                          
      long-term debt, less net debt issuance costs of 170 and 157
    		                          31,019,000,000                                         
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 343,030,500 shares in 2019 and 342,895,200 shares in 2018
    		                          3,000,000                                         
      long-term debt, less net debt issuance costs of 157 and 164
    		                           32,033,000,000                                        
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 342,895,200 shares—2018 and 350,091,600 shares—2017
    		                           3,000,000                                        
      balances, december 31, 2015
    		                           398,739,000    398,739,000    398,739,000    398,739,000                            
      comprehensive income
    		                                                                   
      repurchase of common stock
    		                           -36,325,000 -5,121,000   -31,991,000    -28,583,000    -10,656,000    -10,656,000,000 -750,000,000 -750,000,000  -80,771,000,000    -80,771,000,000                
      share-based benefit plans
    		                           8,122,000 3,280,000   10,252,000    9,457,000    7,060,000    5,722,000,000    3,071,000,000    1,118,000,000                
      distributions
    		                                                                   
      balances, december 31, 2016
    		                           370,536,000 370,536,000   370,536,000    370,536,000                                
      acquisition of entities with noncontrolling interests
    		                                                                   
      balances, december 31, 2017
    		                           350,092,000 350,092,000   350,092,000                                    
      cash dividends declared
    		                                                                   
      net acquisition of entities with noncontrolling interests
    		                                                                   
      reclassification of stranded tax effects
    		                                                                   
      balances, december 31, 2018
    		                           342,895,000                                        
      long-term debt, less net debt issuance costs of 163 and 164
    		                            32,916,000,000                                       
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 345,085,800 shares in 2018 and 350,091,600 shares in 2017
    		                            3,000,000                                       
      balances, march 31, 2017
    		                            368,695,000                                       
      balances, june 30, 2017
    		                            362,895,000                                       
      balances, september 30, 2017
    		                            356,980,000                                       
      balances, march 31, 2018
    		                            350,987,000                                       
      balances, june 30, 2018
    		                            346,760,000                                       
      balances, september 30, 2018
    		                            345,086,000                                       
      long-term debt, less net debt issuance costs of 151 and 164
    		                             31,500,000,000                                      
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 346,760,200 shares in 2018 and 350,091,600 shares in 2017
    		                             3,000,000                                      
      cash flows from operating activities:
    		                                                                   
      net income
    		                             2,248,000,000 1,282,000,000  2,102,000,000 1,572,000,000 777,000,000  2,347,000,000 1,602,000,000 811,000,000  1,958,000,000 1,385,000,000 720,000,000  1,697,000,000 1,086,000,000 454,000,000  1,442,000,000 975,000,000 438,000,000  1,579,000,000 1,124,000,000 639,000,000             
      adjustments to reconcile net income to net cash from operating activities:
    		                                                                   
      increase in cash from operating assets and liabilities:
    		                                                                   
      inventories and other assets
    		                             -200,000,000 -218,000,000  -50,000,000 -178,000,000 3,000,000  -161,000,000 -176,000,000 14,000,000  -205,000,000 -195,000,000 -106,000,000                         
      accounts payable and accrued expenses
    		                             31,000,000 -246,000,000  -169,000,000 -298,000,000 -591,000,000  -341,000,000 -102,000,000 -371,000,000  -152,000,000 -117,000,000 -312,000,000                         
      depreciation and amortization
    		                             1,115,000,000 553,000,000  1,581,000,000 1,042,000,000 521,000,000  1,463,000,000 968,000,000 479,000,000  1,424,000,000 942,000,000 473,000,000  1,361,000,000 901,000,000 447,000,000  1,292,000,000 849,000,000 424,000,000  1,254,000,000 837,000,000 417,000,000             
      income taxes
    		                             118,000,000 246,000,000  -9,000,000 267,000,000 292,000,000  8,000,000 67,000,000 360,000,000  -148,000,000 -101,000,000 438,000,000  -61,000,000 -94,000,000 144,000,000  158,000,000 183,000,000 350,000,000  250,000,000 326,000,000 300,000,000             
      gains on sales of facilities
    		                             -414,000,000 -405,000,000  -10,000,000 -3,000,000   -8,000,000 -5,000,000   -2,000,000 -4,000,000 -9,000,000                         
      amortization of debt issuance costs
    		                             15,000,000 8,000,000  23,000,000 16,000,000 8,000,000  26,000,000 18,000,000 10,000,000  27,000,000 19,000,000 10,000,000                         
      share-based compensation
    		                             134,000,000 60,000,000  195,000,000 140,000,000 73,000,000  196,000,000 129,000,000 65,000,000  171,000,000 103,000,000 48,000,000  118,000,000 77,000,000 37,000,000  81,000,000 51,000,000 23,000,000  39,000,000 23,000,000 9,000,000             
      net cash from operating activities
    		                             2,865,000,000 1,300,000,000  3,692,000,000 2,684,000,000 1,280,000,000  3,954,000,000 2,748,000,000 1,399,000,000  3,176,000,000 2,075,000,000 1,018,000,000  2,821,000,000 1,693,000,000 443,000,000  2,454,000,000 1,554,000,000 740,000,000  2,912,000,000 2,257,000,000 797,000,000             
      cash flows from investing activities:
    		                                                                   
      purchase of property and equipment
    		                             -1,574,000,000 -694,000,000  -2,033,000,000 -1,304,000,000 -571,000,000  -1,884,000,000 -1,172,000,000 -509,000,000  -1,571,000,000 -1,004,000,000 -446,000,000  -1,482,000,000 -913,000,000 -400,000,000  -1,347,000,000 -896,000,000 -404,000,000  -1,268,000,000 -784,000,000 -335,000,000             
      acquisition of hospitals and health care entities
    		                             -538,000,000 -379,000,000  -1,142,000,000 -295,000,000 -90,000,000  -468,000,000 -430,000,000 -9,000,000  -184,000,000 -95,000,000 -28,000,000  -97,000,000 -27,000,000 -19,000,000  -463,000,000 -23,000,000 -22,000,000  -167,000,000 -139,000,000 -112,000,000             
      disposal of hospitals and health care entities
    		                             799,000,000 767,000,000  24,000,000 14,000,000 4,000,000  23,000,000 14,000,000 4,000,000  27,000,000 22,000,000 15,000,000                         
      change in investments
    		                             23,000,000 11,000,000  -15,000,000 -11,000,000 -19,000,000  78,000,000 18,000,000 11,000,000  94,000,000 67,000,000 22,000,000  22,000,000 43,000,000 -13,000,000  97,000,000 102,000,000 51,000,000  73,000,000 35,000,000 6,000,000             
      net cash from investing activities
    		                             -1,315,000,000 -335,000,000  -3,172,000,000 -1,591,000,000 -669,000,000  -2,234,000,000 -1,555,000,000 -496,000,000  -1,631,000,000 -1,009,000,000 -432,000,000  -1,512,000,000 -864,000,000 -409,000,000  -1,674,000,000 -790,000,000 -373,000,000  -1,340,000,000 -886,000,000 -437,000,000             
      cash flows from financing activities:
    		                                                                   
      issuances of long-term debt
    		                                1,502,000,000 1,502,000,000   5,400,000,000 3,000,000,000 3,000,000,000  4,048,000,000 4,048,000,000 1,000,000,000                         
      net change in revolving bank credit facilities
    		                             210,000,000 270,000,000  650,000,000 -1,160,000,000 160,000,000  -70,000,000  -930,000,000  -270,000,000 -300,000,000 -260,000,000                         
      repayment of long-term debt
    		                             -101,000,000 -50,000,000  -700,000,000 -95,000,000 -43,000,000  -4,424,000,000 -2,065,000,000 -2,011,000,000  -3,702,000,000 -3,644,000,000 -791,000,000  -3,525,000,000 -3,482,000,000 -542,000,000  -1,300,000,000 -768,000,000 -741,000,000  -689,000,000 -608,000,000 -93,000,000             
      distributions to noncontrolling interests
    		                             -185,000,000 -92,000,000  -363,000,000 -248,000,000 -145,000,000  -342,000,000 -205,000,000 -111,000,000  -367,000,000 -237,000,000 -132,000,000  -325,000,000 -197,000,000 -87,000,000  -308,000,000 -196,000,000 -102,000,000  -303,000,000 -191,000,000 -93,000,000             
      payment of debt issuance costs
    		                             -2,000,000 -2,000,000  -25,000,000 -25,000,000 -2,000,000  -40,000,000 -24,000,000 -22,000,000  -34,000,000 -33,000,000 -11,000,000  -49,000,000 -49,000,000 -48,000,000  -5,000,000 -5,000,000   -20,000,000 -19,000,000 -16,000,000             
      payment of cash dividends
    		                             -245,000,000 -123,000,000                                     
      repurchases of common stock
    		                             -893,000,000 -423,000,000  -1,475,000,000 -966,000,000 -424,000,000  -2,213,000,000 -1,858,000,000 -621,000,000  -1,386,000,000 -940,000,000 -366,000,000                         
      net cash from financing activities
    		                             -1,408,000,000 -611,000,000  -448,000,000 -1,034,000,000 -504,000,000  -1,784,000,000 -1,243,000,000 -792,000,000  -1,523,000,000 -959,000,000 -566,000,000  -1,208,000,000 -585,000,000 402,000,000  -1,001,000,000 -1,007,000,000 -478,000,000  -1,473,000,000 -1,226,000,000 -262,000,000             
      effect of exchange rate changes on cash and cash equivalents
    		                             -6,000,000                                      
      change in cash and cash equivalents
    		                             136,000,000 354,000,000  72,000,000 59,000,000 107,000,000  -64,000,000 -50,000,000 111,000,000  22,000,000 107,000,000 20,000,000  101,000,000 244,000,000 436,000,000  -221,000,000 -243,000,000 -111,000,000  99,000,000 145,000,000 98,000,000             
      cash and cash equivalents at beginning of period
    		                             732,000,000 732,000,000  646,000,000 646,000,000 646,000,000  741,000,000 741,000,000 741,000,000  566,000,000 566,000,000 566,000,000  414,000,000 414,000,000 414,000,000  705,000,000 705,000,000 705,000,000  373,000,000 373,000,000 373,000,000             
      cash and cash equivalents at end of period
    		                             868,000,000 1,086,000,000  718,000,000 705,000,000 753,000,000  677,000,000 691,000,000 852,000,000  588,000,000 673,000,000 586,000,000  515,000,000 658,000,000 850,000,000  484,000,000 462,000,000 594,000,000  472,000,000 518,000,000 471,000,000             
      interest payments
    		                             873,000,000 549,000,000  1,383,000,000 834,000,000 540,000,000  1,339,000,000 767,000,000 490,000,000  1,349,000,000 810,000,000 487,000,000  1,441,000,000 899,000,000 523,000,000  1,464,000,000 909,000,000 533,000,000  1,404,000,000 854,000,000 517,000,000             
      income tax payments
    		                             411,000,000   911,000,000 387,000,000   890,000,000 558,000,000   864,000,000 581,000,000   758,000,000 517,000,000   476,000,000 226,000,000                  
      long-term debt, less net debt issuance costs of 158 and 164
    		                              31,594,000,000                                     
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 350,987,500 shares in 2018 and 350,091,600 shares in 2017
    		                              4,000,000                                     
      income tax payments (refunds)
    		                              11,000,000                32,000,000      428,000,000 141,000,000              
      accounts receivables
    		                               6,501,000,000 5,980,000,000 5,782,000,000 5,664,000,000 5,826,000,000 5,503,000,000 5,669,000,000 5,880,000,000 5,889,000,000 5,827,000,000 5,804,000,000 5,928,000,000 5,694,000,000 5,524,000,000 5,472,000,000 5,489,000,000 5,208,000,000 4,924,000,000 4,915,000,000 4,877,000,000 4,672,000,000 4,598,000,000 4,485,000,000 4,878,000,000 4,533,000,000 3,925,000,000 3,946,000,000 4,060,000,000 3,832,000,000 3,636,000,000 3,769,000,000 3,878,000,000 3,692,000,000 3,499,000,000 3,680,000,000 3,870,000,000 
      long-term debt, less net debt issuance costs of 164 and 170
    		                               32,858,000,000                                    
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 350,091,600 shares—2017 and 370,535,900 shares—2016
    		                               4,000,000                                    
      balances, december 31, 2014
    		                               420,478,000    420,478,000    420,478,000    420,478,000,000                        
      long-term debt, less net debt issuance costs of 171 and 170
    		                                32,751,000,000                                   
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 356,979,800 shares in 2017 and 370,535,900 shares in 2016
    		                                4,000,000                                   
      benefit from doubtful accounts
    		                                3,104,000,000 1,833,000,000 760,000,000  2,392,000,000 1,552,000,000 790,000,000  2,839,000,000 1,681,000,000 646,000,000  2,337,000,000 1,579,000,000 851,000,000  2,732,000,000 1,777,000,000 754,000,000  2,666,000,000 1,835,000,000 794,000,000             
      losses on retirement of debt
    		                                39,000,000    4,000,000    125,000,000 125,000,000   226,000,000                       
      legal claim costs
    		                                    33,000,000 22,000,000 12,000,000  77,000,000    78,000,000 78,000,000 78,000,000                     
      long-term debt, less net debt issuance costs of 179 and 170
    		                                 31,448,000,000                                  
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 362,895,000 shares in 2017 and 370,535,900 shares in 2016
    		                                 4,000,000                                  
      long-term debt, less net debt issuance costs of 165 and 170
    		                                  31,302,000,000                                 
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 368,694,700 shares in 2017 and 370,535,900 shares in 2016
    		                                  4,000,000                                 
      losses (gains) on sales of facilities
    		                                  -1,000,000    1,000,000      -20,000,000 -32,000,000 -21,000,000  13,000,000    -4,000,000               
      income tax refunds
    		                                  -3,000,000    -76,000,000            -185,000,000    -25,000,000             
      long-term debt, less net debt issuance costs of 170 and 167
    		                                   31,160,000,000                                
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 370,535,900 shares — 2016 and 398,738,700 shares — 2015
    		                                   4,000,000                                
      stockholders’ deficit attributable to hca holdings, inc.
    		                                   -7,302,000,000 -7,763,000,000 -8,107,000,000 -7,556,000,000 -7,599,000,000 -7,294,000,000 -7,406,000,000 -7,620,000,000 -7,894,000,000 -7,384,000,000 -7,990,000,000 -7,828,000,000 -8,270,000,000 -8,376,000,000 -8,823,000,000 -9,323,000,000 -9,660,000,000 -7,859,000,000 -8,243,000,000 -8,613,000,000 -8,258,000,000 -10,194,000,000 -8,681,000,000 -8,930,000,000 -11,926,000,000        
      balances, december 31, 2013
    		                                   439,604,000    439,604,000    439,604,000,000    439,604,000,000                    
      long-term debt, less net debt issuance costs of 178 and 167
    		                                    31,225,000,000                               
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 376,140,800 shares in 2016 and 398,738,700 shares in 2015
    		                                    4,000,000                               
      long-term debt, less net debt issuance costs of 173 and 167
    		                                     31,228,000,000                              
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 380,061,600 shares in 2016 and 398,738,700 shares in 2015
    		                                     4,000,000                              
      long-term debt, less net debt issuance costs of 179 and 167
    		                                      30,328,000,000                             
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 393,650,000 shares in 2016 and 398,738,700 shares in 2015
    		                                      4,000,000                             
      deferred income taxes
    		                                        412,000,000 376,000,000 304,000,000 366,000,000 320,000,000 500,000,000 492,000,000 489,000,000 400,000,000 401,000,000 385,000,000 385,000,000 322,000,000 323,000,000 226,000,000 594,000,000 643,000,000 894,000,000 916,000,000 931,000,000 1,045,000,000 1,126,000,000 1,181,000,000 1,192,000,000 1,099,000,000 1,032,000,000 988,000,000 
      long-term debt, less net debt issuance costs of 167 and 219
    		                                       30,255,000,000  28,363,000,000                          
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 398,738,700 shares — 2015 and 420,477,900 shares — 2014
    		                                       4,000,000                            
      balances, december 31, 2012
    		                                       443,200,000    443,200,000,000    443,200,000,000    443,200,000,000                
      long-term debt, less net debt issuance costs of 160 and 219
    		                                        28,375,000,000                           
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 412,638,300 shares in 2015 and 420,477,900 shares in 2014
    		                                        4,000,000                           
      decrease in cash from operating assets and liabilities:
    		                                                                   
      income tax benefits
    		                                        231,000,000 197,000,000 38,000,000  119,000,000 75,000,000 50,000,000  70,000,000 61,000,000 36,000,000  82,000,000 71,000,000 49,000,000             
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 416,348,900 shares in 2015 and 420,477,900 shares in 2014
    		                                         4,000,000                          
      long-term debt, less debt issuance costs of 220 and 219
    		                                          27,406,000,000                         
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 419,179,100 shares in 2015 and 420,477,900 shares in 2014
    		                                          4,000,000                         
      distributions to stockholders
    		                                          -6,000,000  -7,000,000 -7,000,000 -7,000,000  -13,000,000 -10,000,000 -10,000,000  -983,000,000 -982,000,000 -982,000,000             
      income tax (refunds) payments
    		                                          -118,000,000                         
      deferred loan costs
    		                                           219,000,000 221,000,000 230,000,000 271,000,000 237,000,000 250,000,000 264,000,000 274,000,000 290,000,000 266,000,000 281,000,000 292,000,000 290,000,000 297,000,000 332,000,000 354,000,000 374,000,000 371,000,000 391,000,000 411,000,000 418,000,000 436,000,000 444,000,000 452,000,000 
      long-term debt
    		                                           29,307,000,000 27,426,000,000 27,942,000,000 27,883,000,000 27,590,000,000 27,389,000,000 26,744,000,000 27,170,000,000 27,495,000,000 25,182,000,000 25,732,000,000 26,061,000,000 25,645,000,000 25,871,000,000 24,631,000,000 24,820,000,000 27,633,000,000 25,383,000,000 25,769,000,000 25,874,000,000 24,824,000,000 25,279,000,000 26,351,000,000 26,151,000,000 
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 420,477,900 shares — 2014 and 439,604,000 shares — 2013
    		                                           4,000,000                        
      balances, december 31, 2011
    		                                           437,478,000,000    437,478,000,000    437,478,000,000                
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 433,378,700 shares in 2014 and 439,604,000 shares in 2013
    		                                            4,000,000                       
      changes in operating assets and liabilities
    		                                            -2,945,000,000 -2,151,000,000 -1,561,000,000  -3,319,000,000 -2,335,000,000 -1,294,000,000  -2,923,000,000 -1,927,000,000 -1,384,000,000             
      amortization of deferred loan costs
    		                                            33,000,000 23,000,000 14,000,000  41,000,000 28,000,000 13,000,000  44,000,000 29,000,000 14,000,000             
      disposition of hospitals and health care entities
    		                                            38,000,000 32,000,000 23,000,000  31,000,000 31,000,000 1,000,000  17,000,000 6,000,000 1,000,000             
      issuance of long-term debt
    		                                            3,502,000,000 3,502,000,000 3,502,000,000      1,350,000,000 1,350,000,000 1,350,000,000             
      net change in revolving credit facilities
    		                                            -160,000,000 340,000,000 -2,440,000,000  630,000,000 -20,000,000 390,000,000  -875,000,000 -820,000,000 -470,000,000             
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 431,372,800 shares in 2014 and 439,604,000 shares in 2013
    		                                             4,000,000                      
      loss on retirement of debt
    		                                             226,000,000   17,000,000 17,000,000 17,000,000                 
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 444,201,100 shares in 2014 and 439,604,000 shares in 2013
    		                                              4,000,000                     
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 439,604,000 shares — 2013 and 443,200,200 shares — 2012
    		                                               4,000,000                    
      balances, december 31, 2010
    		                                               427,459,000,000    427,459,000,000                
      issuance of common stock
    		                                               87,719,000,000    87,719,000,000                
      consolidation of acquired controlling interest in equity investment
    		                                                                   
      reclassification of equity securities with contingent redemption rights
    		                                                                   
      adjustment to the acquired controlling interest in equity investment
    		                                                                   
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 447,573,400 shares in 2013 and 443,200,200 shares in 2012
    		                                                4,000,000                   
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 447,066,900 shares in 2013 and 443,200,200 shares in 2012
    		                                                 4,000,000                  
      losses on sales of facilities
    		                                                 12,000,000 16,000,000   3,000,000 1,000,000             
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 445,856,200 shares in 2013 and 443,200,200 shares in 2012
    		                                                  4,000,000                 
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 443,200,200 shares — 2012 and 437,477,900 shares — 2011
    		                                                   4,000,000                
      balances, december 31, 2009
    		                                                   426,341,000,000                
      contributions
    		                                                                   
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 441,383,000 shares in 2012 and 437,477,900 shares in 2011
    		                                                    4,000,000               
      pay-in-kind interest
    		                                                                   
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 440,483,600 shares in 2012 and 437,477,900 shares in 2011
    		                                                     4,000,000              
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 438,354,100 shares in 2012 and 437,477,900 shares in 2011
    		                                                      4,000,000             
      equity securities with contingent redemption rights
    		                                                           141,000,000 144,000,000 144,000,000 144,000,000 147,000,000 147,000,000 155,000,000 154,000,000 
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 437,477,900 shares — 2011 and 427,458,800 shares — 2010
    		                                                       4,000,000            
      investments of insurance subsidiary
    		                                                        545,000,000 515,000,000 590,000,000 642,000,000 665,000,000 646,000,000 1,146,000,000 1,166,000,000 1,371,000,000 1,322,000,000 1,302,000,000 
      goodwill
    		                                                        2,701,000,000 2,719,000,000 2,705,000,000 2,693,000,000 2,610,000,000 2,583,000,000 2,561,000,000 2,577,000,000 2,596,000,000 2,594,000,000 2,579,000,000 
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 436,483,900 shares in 2011 and 427,458,800 shares in 2010
    		                                                        4,000,000           
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 517,094,100 shares in 2011 and 427,458,800 shares in 2010
    		                                                         5,000,000          
      common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 515,614,300 shares in 2011 and 427,458,800 shares in 2010
    		                                                          5,000,000         
      common stock 0.01 par; authorized 125,000,000 shares — 2010 and 2009; outstanding 94,885,500 shares — 2010 and 94,637,400 shares — 2009
    		                                                           1,000,000        
      common stock 0.01 par; authorized 125,000,000 shares; outstanding 94,644,100 shares in 2010 and 94,637,400 shares in 2009
    		                                                            1,000,000       
      stockholders’ deficit attributable to hca inc.
    		                                                            -10,259,000,000 -10,525,000,000 -10,313,000,000 -8,986,000,000 -9,279,000,000 -9,486,000,000 -9,888,000,000 
      common stock 0.01 par; authorized 125,000,000 shares; outstanding 94,638,800 shares in 2010 and 94,637,400 shares in 2009
    		                                                             1,000,000      
      common stock 0.01 par; authorized 125,000,000 shares; outstanding 94,626,100 shares in 2010 and 94,637,400 shares in 2009
    		                                                              1,000,000     
      common stock 0.01 par; authorized 125,000,000 shares — 2009 and 2008; outstanding 94,637,400 shares — 2009 and 94,367,500 shares — 2008
    		                                                               1,000,000    
      common stock .01 par; authorized 125,000,000 shares; outstanding 94,614,500 shares in 2009 and 94,367,500 shares in 2008
    		                                                                1,000,000   
      common stock .01 par; authorized 125,000,000 shares; outstanding 94,409,800 shares in 2009 and 94,367,500 shares in 2008
    		                                                                 1,000,000  
      common stock .01 par; authorized 125,000,000 shares; outstanding 94,378,600 shares in 2009 and 94,367,500 shares in 2008
    		                                                                  1,000,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.